Palisade Bio (PALI) Payables (2010 - 2026)

Palisade Bio (PALI) has reported Payables for 17 consecutive years, with $2.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Payables rose 261.88% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.7 million (up 261.88% YoY), while the FY2025 annual figure was $767000.0, down 30.59% from the prior year.
• Payables climbed to $2.7 million in Q1 2026 per PALI's latest filing, from $767000.0 in the prior quarter.
• Across five years, Payables topped out at $2.7 million in Q1 2026 and bottomed at $366000.0 in Q3 2024.
• Historically, Payables has averaged $1.1 million across 5 years, with a median of $950000.0 in 2023.
• Annual changes were most pronounced in 2024 — Payables plunged 61.47% — and 2025, when it soared 289.62%.
• Palisade Bio's Payables stood at $1.8 million in 2022, then sank by 60.32% to $698000.0 in 2023, then jumped by 58.31% to $1.1 million in 2024, then tumbled by 30.59% to $767000.0 in 2025, then soared by 251.5% to $2.7 million in 2026.
• Business Quant data shows PALI's Payables at $2.7 million in Q1 2026, $767000.0 in Q4 2025, and $1.4 million in Q3 2025.